Elicio Therapeutics(DE:9HA)
€1.47+0.16 (+12.21%)
DE:9HA
Elicio Therapeutics ownership
€1.47
At close:+0.16 (+12.21%)
Elicio Therapeutics (9HA) Ownership - Who Owns Elicio Therapeutics?
0 Followers
Elicio Therapeutics (9HA) Ownership Overview
- 20.59% Insiders
- 3.53% Mutual Funds
- 4.64% Other Institutional Investors
- 4.18% ETFs
- 67.05% Public Companies and Individual Investors
The ownership structure of Elicio Therapeutics (DE:9HA) stock is a mix of institutional, retail, and individual investors. Approximately 12.35% of the company’s stock is owned by Institutional Investors, 20.59% is owned by Insiders, and 67.05% is owned by Public Companies and Individual Investors.
The ownership structure of Elicio Therapeutics (DE:9HA) stock is a mix of institutional, retail, and individual investors. Approximately 12.35% of the company’s stock is owned by Institutional Investors, 20.59% is owned by Insiders, and 67.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Yekaterina Chudnovsky | 5,416,212 | Insider | 19.13% | 8,384,296 |
| BlackRock, Inc. | 766,005 | Institution | 2.71% | 1,185,776 |
| Vanguard | 666,975 | Institution | 2.36% | 1,032,477 |
| Vanguard Index Funds | 558,997 | Institution | 1.97% | 865,327 |
| Ishares | 494,417 | Institution | 1.75% | 765,358 |
| Jay Venkatesan | 180,534 | Insider | 0.64% | 279,467 |
| Fidelity Salem Street Trust | 152,027 | Institution | 0.54% | 235,338 |
| Robert Connelly | 120,570 | Insider | 0.43% | 186,642 |
| Fidelity Concord Street Trust | 118,421 | Institution | 0.42% | 183,316 |
| Vanguard Scottsdale Funds | 89,566 | Institution | 0.32% | 138,648 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 558,997 | Institution | 1.97% | 865,327 |
| Fidelity Salem Street Trust | 152,027 | Institution | 0.54% | 235,338 |
| Fidelity Concord Street Trust | 118,421 | Institution | 0.42% | 183,316 |
| Vanguard Scottsdale Funds | 89,566 | Institution | 0.32% | 138,648 |
| Schwab Capital Trust | 31,706 | Institution | 0.11% | 49,081 |
| Tiaa-cref Funds | 17,888 | Institution | 0.06% | 27,691 |
| Valic Co I | 6,630 | Institution | 0.02% | 10,263 |
| Vanguard Institutional Index Funds | 6,579 | Institution | 0.02% | 10,184 |
| Vanguard Valley Forge Funds | 6,575 | Institution | 0.02% | 10,178 |
| State Street Institutional Investment Trust | 3,500 | Institution | 0.01% | 5,418 |
FAQ
Who Owns Elicio Therapeutics (DE:9HA)?
According to the latest TipRanks data, approximately 12.35% of the company's stock is held by institutional investors, 20.59% is held by insiders, and 67.05% is held by public companies and individual investors.
What percentage of Elicio Therapeutics (DE:9HA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.35% of Elicio Therapeutics (DE:9HA) stock is held by institutional investors: 3.53% by mutual funds, 4.18% by ETFs and 4.64% by other institutional investors.
What percentage of Elicio Therapeutics (DE:9HA) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.05% of Elicio Therapeutics (DE:9HA) stock is held by public companies and individual investors.
Who owns the most shares of Elicio Therapeutics (DE:9HA)?
Yekaterina Chudnovsky owns the most shares of Elicio Therapeutics (DE:9HA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
